Publications

Journal Article
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 424 citations
Electronic publication date
March 10, 2001

View on Pubmed.gov 11160142 | View on doi.org 10.1172/JCI1055...

Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4.

Search for publications in this journal J Clin Invest - 107(2):R9-R14

Abstract

The syndecans make up a family of transmembrane heparan sulfate proteoglycans that act as coreceptors with integrins and growth factor tyrosine kinase receptors. Syndecan-4 is upregulated in skin dermis after wounding, and, in cultured fibroblasts adherent to the ECM protein fibronectin, this proteoglycan signals cooperatively with beta1 integrins. In this study, we generated mice in which the syndecan-4 gene was disrupted by homologous recombination in embryonic stem cells to test the hypothesis that syndecan-4 contributes to wound repair. Mice heterozygous or homozygous for the disrupted syndecan-4 gene are viable, fertile, and macroscopically indistinguishable from wild-type littermates. Compared with wild-type littermates, mice heterozygous or homozygous for the disrupted gene have statistically significant delayed healing of skin wounds and impaired angiogenesis in the granulation tissue. These results indicate that syndecan-4 is an important cell-surface receptor in wound healing and angiogenesis and that syndecan-4 is haplo-insufficient in these processes.

References

J Invest Dermatol. 1999 Nov;113(5):782-7

J Cell Sci. 1999 Oct;112 ( Pt 20):3433-41

J Biol Chem. 2000 Feb 25;275(8):5249-52

Annu Rev Biochem. 1999;68:729-77

Cited by 424 citations (total)

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Syndecan-4: dispensable or indispensable?

Electronic publication date January 27, 2004

Search for publications in this journal Glycoconj J

Sarah A Wilcox-Adelman [...] Paul F Goetinck et al.

Studies examining the role of the cell-surface heparan sulfate proteoglycan syndecan-4 have yielded a plethora of information regarding its role...

Journal Article Research Support, Non-U.S. Gov't Review

Scar wars: is TGFbeta the phantom menace in scleroderma?

Electronic publication date February 21, 2007

Search for publications in this journal Arthritis Res Ther

Andrew Leask

The autoimmune disease scleroderma (systemic sclerosis (SSc)) is characterized by extensive tissue fibrosis, causing significant morbidity. There is no therapy...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances